Abeona Therapeutics Inc vs Invesco DB Oil Fund — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Invesco DB Oil Fund trades at $21.06. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Invesco DB Oil Fund nearer its low. Which is the better fit depends on your goals.
| ABEO | DBO | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Commodities - Energy |
52-Week High | $7.45 | $23.80 |
52-Week Low | $4.17 | $11.98 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →